Background and Experience

---

Lucy has been consulting to IVD test manufacturers since 2015 supporting more than 20 companies and building a deep understanding of the road to market for IVD tests from product concept to launch.  She also works for various organisations in the global public health sector where the emphasis is on building access to diagnostics in low- and middle- income countries (LMICs).  She was a member of the initial team that established the WHO Model List of Essential Diagnostics.  She has 30 years of experience commercializing products in the Life Science Research and Diagnostics industries, with much of that time in molecular diagnostics.  She has managed sales and marketing teams in South Africa and Canada, and has led marketing teams with global responsibility for more than 10 years.  She has successfully commercialized IVD tests in diverse market environments - emerging economies and developed markets, markets with both public and private healthcare systems, and innovative new markets as well as competitive, mature markets.  She worked for Roche Diagnostics for many years in various roles, and subsequently led diagnostics programs for GenProbe Inc. (now Hologic) and Singulex.  She holds a Bachelor of Science Honours degree in Medical Biochemistry from the University of Cape Town Medical School, and an MBA from IMD in Switzerland.

• Led a complex diagnostics instrument and assay development program with a multidisciplinary, matrix team (including representatives for Product Development, Regulatory Affairs, Clinical Operations, and Manufacturing) as well as an external instrument development partner.   
• Supervised the Project Manager and Marketing team. 
• The technology was a novel technology, which meant that it's value in clinical diagnostics had to be defined through selection of optimal menu.
• The company had no lab targeted commercial organisation and a small budget and the commercialisation strategy for Europe and the US had to be developed from scratch.  
• Prepared a clinical study strategy supporting new intended uses for the lead assay, High Sensitivity Troponin

• Directed the Gen-Probe HPV Segment multidisciplinary team charged with bringing Gen-Probe's APTIMA HPV product portfolio to market. 
• Supervised a Project Manager and the Marketing team and led the matrix team of all product development functions including Development, Regulatory, Quality, & Operations personnel. 
• The team delivered project milestones on time and on budget and forged important relationships with major reference labs, KOL's and advocacy groups, which led to the successful signing of large contracts.

• Directed global marketing teams in 3 consecutive roles managing PCR tests for HIV viral load, Microbiology and CT/NG and developed knowledge of the global Molecular Diagnostics market for HIV, Hospital Acquired Infections, Sepsis and Sexually Transmitted Diseases
• Gained experience working with Global Public Health organisations such as WHO and Clinton Foundation while working on HIV
• Worked on marketing activities for products at all stages of the product development life cycle from concept through launch and post launch promotion
• Collaborated closely with local sales and marketing teams all over the world

• Responsible for the Roche Molecular Diagnostics and Roche Applied Science Businesses in South Africa and then in Canada
• Led the local sales, marketing and technical support teams in those countries
• Developed an understanding of the Life Science Research market, as well as the Molecular Diagnostics and Blood Screening markets
• Gained experience working in countries with both public and private healthcare systems